Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 249,548 | -84,031 | -111,790 | -72,253 | -36,102 |
| Depreciation Amortization | 14,850 | 61,398 | 45,947 | 31,378 | 16,415 |
| Income taxes - deferred | 1,212 | 16,961 | 23,544 | 22,858 | 2,060 |
| Accounts receivable | -7,798 | -39,095 | -9,760 | -12,954 | -2,512 |
| Accounts payable and accrued liabilities | 717 | -11,745 | -21,532 | -23,821 | -343 |
| Other Working Capital | -69,938 | -4,988 | -44,041 | -77,110 | -49,147 |
| Other Operating Activity | 77,101 | 297,603 | 209,011 | 157,625 | 54,492 |
| Operating Cash Flow | $265,692 | $236,103 | $91,379 | $25,723 | $-15,137 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,099 | -56,563 | -41,775 | -27,892 | -11,974 |
| Purchase Of Investment | -248,273 | -629,700 | -639,700 | -470,236 | -224,624 |
| Sale Of Investment | 98,393 | 757,562 | 535,379 | 332,316 | 131,173 |
| Other Investing Activity | 0 | -20,061 | 20,397 | 5,322 | 2,717 |
| Investing Cash Flow | $-160,979 | $51,238 | $-125,699 | $-160,490 | $-102,708 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 86,173 | 2,030 | N/A | N/A |
| Debt Repayment | -4,703 | -92,597 | -13,330 | -7,538 | -4,041 |
| Common Stock Issued | 11,249 | 68,230 | 51,165 | 33,702 | 8,846 |
| Other Financing Activity | -296,111 | 71,465 | -356 | -209 | -103 |
| Financing Cash Flow | $-289,565 | $133,271 | $39,509 | $25,955 | $4,702 |
| Exchange Rate Effect | 1,388 | -4,666 | -265 | -90 | 2,620 |
| Beginning Cash Position | 1,231,707 | 815,761 | 714,768 | 714,768 | 714,768 |
| End Cash Position | 1,048,243 | 1,231,707 | 719,692 | 605,866 | 604,245 |
| Net Cash Flow | $-183,464 | $415,946 | $4,924 | $-108,902 | $-110,523 |
| Free Cash Flow | |||||
| Operating Cash Flow | 265,692 | 236,103 | 91,379 | 25,723 | -15,137 |
| Capital Expenditure | -11,099 | -56,563 | -41,775 | -27,892 | -11,974 |
| Free Cash Flow | 254,593 | 179,540 | 49,604 | -2,169 | -27,111 |